AGAP2 and non-small cell lung carcinoma: According to relative AGAP2-AS1 expression in tumor tissues, the 80 NSCLC patients were classified into two groups: the high AGAP2-AS1 group (n=40, fold change ≥mean ratio) and the low AGAP2-AS1 group (n=40, fold change ≤mean ratio; Figure 1c).